Phagocyte-derived catecholamines enhance acute inflammatory injury

Area of Science:

• Immunology
• Neuroscience
• Cell Biology

Background:

• The autonomic and immune systems interact during inflammation via sympathetic and parasympathetic pathways.
• Lymphocytes can produce catecholamines, suggesting a self-regulatory mechanism during inflammation.

Purpose of the Study:

• To investigate if phagocytes can produce catecholamines de novo.
• To determine the role of phagocyte-derived catecholamines in inflammation and acute lung injury.

Main Methods:

• Exposure of phagocytes to lipopolysaccharide (LPS) to assess catecholamine production and enzyme activity.
• In vivo studies using two models of acute lung injury.
• Pharmacological manipulation including blockade of alpha2-adrenoreceptors and modulation of catecholamine-generating/degrading enzymes.

Main Results:

• Phagocytes exposed to LPS released catecholamines and showed induced catecholamine-generating and degrading enzymes.
• Blockade of alpha2-adrenoreceptors or catecholamine-generating enzymes suppressed lung inflammation.
• Activation of alpha2-adrenoreceptors or inhibition of catecholamine-degrading enzymes exacerbated lung inflammation.
• T cells and sympathetic nerve endings were excluded as sources of these modulating catecholamines.

Conclusions:

• Phagocytes possess the complete machinery for catecholamine generation, release, and inactivation.
• Phagocytes are a novel source of catecholamines that enhance inflammatory responses.
• Phagocyte-derived catecholamines play a significant role in modulating acute lung injury.